InsiderClue
Stocks · Health care · Services-Medical Laboratories

Guardant Health, Inc.

GH Clue Score47
United States Fiscal year ends December CIK 0001576280
$167.47 +1.15% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $167.47 +61.65% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 4 Oct 2018. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2017Revenue49.8Operating income−76.6Net income−83.2Fiscal year 2018Revenue90.6 +81.9%Operating income−92.9Net income−85.1Fiscal year 2019Revenue214.4 +136.5%Operating income−82.4Net income−75.7EPS, diluted−0.84Fiscal year 2020Revenue286.7 +33.8%Operating income−255.0Net income−246.3EPS, diluted−2.60Fiscal year 2021Revenue373.7 +30.3%Operating income−411.0Net income−384.8EPS, diluted−4.00Fiscal year 2022Revenue449.5 +20.3%Operating income−544.4Net income−654.6EPS, diluted−6.41Fiscal year 2023Revenue563.9 +25.5%Operating income−564.7Net income−479.4EPS, diluted−4.28Fiscal year 2024Revenue739.0 +31.0%Operating income−443.6Net income−436.4EPS, diluted−3.56Fiscal year 2025Revenue982.0 +32.9%Operating income−437.2Net income−416.3EPS, diluted−3.32
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 49.8 90.6 214.4 286.7 373.7 449.5 563.9 739.0 982.0
Growth +81.9% +136.5% +33.8% +30.3% +20.3% +25.5% +31.0% +32.9%
Operating income −76.6 −92.9 −82.4 −255.0 −411.0 −544.4 −564.7 −443.6 −437.2
Net income −83.2 −85.1 −75.7 −246.3 −384.8 −654.6 −479.4 −436.4 −416.3
Growth
EPS, diluted n/a n/a −0.84 −2.60 −4.00 −6.41 −4.28 −3.56 −3.32
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2017Operating margin−153.7%Net margin−167.0%Free cash flow margin−158.3%Fiscal year 2018Operating margin−102.5%Net margin−93.8%Free cash flow margin−101.9%Fiscal year 2019Operating margin−38.4%Net margin−35.3%Free cash flow margin−30.7%Fiscal year 2020Operating margin−88.9%Net margin−85.9%Free cash flow margin−48.9%Fiscal year 2021Operating margin−110.0%Net margin−103.0%Free cash flow margin−76.0%Fiscal year 2022Operating margin−121.1%Net margin−145.6%Free cash flow margin−86.1%Fiscal year 2023Operating margin−100.1%Net margin−85.0%Free cash flow margin−61.3%Fiscal year 2024Operating margin−60.0%Net margin−59.0%Free cash flow margin−37.2%Fiscal year 2025Operating margin−44.5%Net margin−42.4%Free cash flow margin−23.7%
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −153.7% −102.5% −38.4% −88.9% −110.0% −121.1% −100.1% −60.0% −44.5%
Net margin −167.0% −93.8% −35.3% −85.9% −103.0% −145.6% −85.0% −59.0% −42.4%
Free cash flow margin −158.3% −101.9% −30.7% −48.9% −76.0% −86.1% −61.3% −37.2% −23.7%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow−72.2Capital expenditure−6.7Free cash flow−78.9Buybacks−7.2Fiscal year 2018Operating cash flow−72.2Capital expenditure−20.2Free cash flow−92.4Buybacks−0.2Fiscal year 2019Operating cash flow−47.1Capital expenditure−18.7Free cash flow−65.9Buybacks0.0Fiscal year 2020Operating cash flow−103.9Capital expenditure−36.2Free cash flow−140.1Buybacks0.0Fiscal year 2021Operating cash flow−209.0Capital expenditure−75.0Free cash flow−284.1Fiscal year 2022Operating cash flow−309.5Capital expenditure−77.5Free cash flow−386.9Fiscal year 2023Operating cash flow−325.0Capital expenditure−20.5Free cash flow−345.5Buybacks0.0Fiscal year 2024Operating cash flow−239.9Capital expenditure−35.1Free cash flow−274.9Buybacks0.0Fiscal year 2025Operating cash flow−184.8Capital expenditure−48.3Free cash flow−233.1Buybacks−45.0
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −72.2 −72.2 −47.1 −103.9 −209.0 −309.5 −325.0 −239.9 −184.8
Capital expenditure −6.7 −20.2 −18.7 −36.2 −75.0 −77.5 −20.5 −35.1 −48.3
Free cash flow −78.9 −92.4 −65.9 −140.1 −284.1 −386.9 −345.5 −274.9 −233.1
Growth
Buybacks −7.2 −0.2 0.0 0.0 n/a n/a 0.0 0.0 −45.0

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2017Cash72.3Shareholders’ equity308.6Fiscal year 2018Cash140.5Shareholders’ equity483.2Fiscal year 2019Cash143.2Shareholders’ equity798.4Fiscal year 2020Cash833.0Shareholders’ equity1,298.5Fiscal year 2021Cash492.2Shareholders’ equity645.0Fiscal year 2022Cash141.6Shareholders’ equity60.2Fiscal year 2023Cash1,133.5Shareholders’ equity158.7Fiscal year 2024Cash525.5Total debt1,142.5Net cash (debt)−617.0Shareholders’ equity−139.6Fiscal year 2025Cash378.2Total debt1,504.0Net cash (debt)−1,125.8Shareholders’ equity−99.3
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 72.3 140.5 143.2 833.0 492.2 141.6 1,133.5 525.5 378.2
Total debt n/a n/a n/a n/a n/a n/a n/a 1,142.5 1,504.0
Net cash (debt) n/a n/a n/a n/a n/a n/a n/a −617.0 −1,125.8
Shareholders’ equity 308.6 483.2 798.4 1,298.5 645.0 60.2 158.7 −139.6 −99.3

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
49.8 90.6 214.4 286.7 373.7 449.5 563.9 739.0 982.0
Growth +81.9% +136.5% +33.8% +30.3% +20.3% +25.5% +31.0% +32.9%
n/a n/a n/a n/a n/a n/a 227.1 289.8 349.0
25.6 50.7 86.3 149.9 263.2 373.8 367.2 347.8 364.2
36.8 36.2 61.4 192.8 206.6 164.0 155.8 180.1 211.4
−76.6 −92.9 −82.4 −255.0 −411.0 −544.4 −564.7 −443.6 −437.2
Growth
−83.2 −84.2 −69.7 −245.9 −384.5 −653.4 −478.8 −435.1 −417.5
0.0 0.0 −1.9 0.4 0.3 1.1 0.7 1.3 −1.3
−83.2 −85.1 −75.7 −246.3 −384.8 −654.6 −479.4 −436.4 −416.3
Growth
Per share
n/a n/a −0.84 −2.60 −4.00 −6.41 −4.28 −3.56 −3.32
n/a n/a −0.84 −2.60 −4.00 −6.41 −4.28 −3.56 −3.32
Growth
n/a n/a 90.6 97.5 101.3 102.2 112.0 122.7 125.4
n/a n/a 90.6 97.5 101.3 102.2 112.0 122.7 125.4
Growth +7.6% +3.9% +0.9% +9.6% +9.6% +2.1%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 27.9% a year over five years.
  • The diluted share count rose 28.6% in five years, which is dilution.
  • Operating margin is up 44.4 points on five years ago, at -44.5%.
  • A net loss in 9 of 9 years on file.